Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study

Background: This study assessed the quality of life (QoL) and the implication of time effort of everolimus treatment in patients with metastatic renal cell carcinoma (mRCC). Methods: Adult patients with mRCC were eligible for everolimus treatment after first-line vascular endothelial growth factor r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncology research and treatment 2019-01, Vol.42 (1-2), p.57-66
Hauptverfasser:	Goebell, Peter J., Hermann, Edwin, Kube, Ulrich, Doehn, Christian, Marschner, Norbert, Dietel, Anja, Blumenstengel, Katja, Grimm, Marc-Oliver, Scheffler, Michael, Rogler, Anja, Bergmann, Lothar
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!